Loading
PDBj
✖
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

29AI

Crystal structure of EcLpxC complexed with compound 7a

This is a non-PDB format compatible entry.
Summary for 29AI
Entry DOI10.2210/pdb29ai/pdb
DescriptorUDP-3-O-acyl-N-acetylglucosamine deacetylase, ZINC ION, 5-oxidanyl-4-[2-[4-[2-[4-[[(3-oxidanylcyclobutyl)amino]methyl]phenyl]ethynyl]phenyl]ethyl]-1~{H}-pyrimidin-6-one, ... (5 entities in total)
Functional Keywordslpxc, metalloprotease, antibiotic, inhibitor
Biological sourceEscherichia coli
Total number of polymer chains4
Total formula weight132368.25
Authors
Beaumont, E.,Cade, I.,Kopec, J.,Martin, D. (deposition date: 2026-03-03, release date: 2026-07-29, Last modification date: 2026-08-26)
Primary citationMartin, D.P.,Teng, M.,Nammalwar, B.,Perez, C.,Li, X.,Munguia, J.,Taganov, K.,Fan, J.,Agarwalla, S.,Lonergan, D.,Tomaras, A.P.,Zimmerman, Z.,Puerta, D.T.
Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections.
J.Med.Chem., 69:18692-18704, 2026
Cited by
PubMed Abstract: This report summarizes the discovery and optimization of a novel series of nonhydroxamate inhibitors targeting LpxC, a Zn2+-dependent hydrolase that is essential for the survival of Gram-negative bacteria. Beginning with a 5-hydroxypyrimidin-4-one metal-binding pharmacophore, structure-based approaches were utilized to generate a series of potent inhibitors that exhibited activity against a wide variety of Enterobacterales, including both susceptible and multidrug-resistant pathogens, and efficacy in murine thigh infection models. These novel compounds were evaluated in a rat model of cardiovascular toxicity to demonstrate the safety of the scaffold relative to another LpxC inhibitor that proved unsuccessful in Phase I clinical trials. A variety of inhibitors with potent in vivo efficacy and no hemodynamic effects were identified, which constituted an initial suite of potential development candidates.
PubMed: 42593942
DOI: 10.1021/acs.jmedchem.6c01036
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.618 Å)
Structure validation

260626

PDB entries from 2026-10-07

PDB statisticsPDBj update infoContact PDBjnumon